4. MannKind Corp. (MNKD, Earnings, Analysts, Financials): Focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Market cap at $508.76M, most recent closing price at $2.07. Shares shorted have decreased from 27.11M to 25.51M over the last month, a decrease which represents about 1.27% of the company’s float of 126.38M shares. Days to cover ratio at 9.73 days.

http://wire.kapitall.com/investment-idea/short-sellers-think-these-7-biotech-stocks-have-more-upside/